ProfileGDS4718 / 213807_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 43% 40% 39% 43% 41% 56% 51% 40% 49% 44% 42% 46% 47% 52% 46% 43% 44% 57% 46% 42% 43% 41% 36% 43% 43% 43% 41% 42% 42% 54% 48% 51% 43% 42% 49% 51% 50% 38% 45% 36% 45% 53% 54% 50% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1677643
GSM549102patient 115, normal, homogenized [OPG study]5.0295340
GSM549104patient 119, normal, homogenized [OPG study]4.9143539
GSM549108patient 138, normal, homogenized [OPG study]5.1935543
GSM549119patient 077, normal, homogenized [OPG study]5.0457841
GSM549133patient 032, cancer, homogenized [OPG study]5.8344356
GSM549139patient 042, cancer, homogenized [OPG study]5.554651
GSM549099patient 107, normal, homogenized [OPG study]5.0183140
GSM549109patient 139, normal, homogenized [OPG study]5.4667749
GSM549110patient 046, normal, homogenized [OPG study]5.1741644
GSM549114patient 063, normal, homogenized [OPG study]5.0243342
GSM549122patient 082, normal, homogenized [OPG study]5.28346
GSM549134patient 033, cancer, homogenized [OPG study]5.3521147
GSM549136patient 036, cancer, homogenized [OPG study]5.6086252
GSM549140patient 044, cancer, homogenized [OPG study]5.2595646
GSM549111patient 047, normal, homogenized [OPG study]5.1146343
GSM549113patient 057, normal, homogenized [OPG study]5.1322944
GSM549132patient 031, cancer, homogenized [OPG study]5.9317657
GSM549137patient 038, cancer, homogenized [OPG study]5.2883446
GSM549142patient 047, cancer, homogenized [OPG study]5.2061442
GSM549100patient 110, normal, homogenized [OPG study]5.1810743
GSM549107patient 135, normal, homogenized [OPG study]4.992641
GSM549115patient 068, normal, homogenized [OPG study]4.7599136
GSM549116patient 072, normal, homogenized [OPG study]5.1160243
GSM549120patient 078, normal, homogenized [OPG study]5.1589843
GSM549131patient 030, cancer, homogenized [OPG study]5.0914443
GSM549118patient 074, normal, homogenized [OPG study]5.022341
GSM549129patient 027, cancer, homogenized [OPG study]5.1303142
GSM549123patient 088, normal, homogenized [OPG study]5.0820142
GSM549124patient 006, cancer, homogenized [OPG study]5.7824754
GSM549126patient 015, cancer, homogenized [OPG study]5.4057548
GSM549128patient 025, cancer, homogenized [OPG study]5.5884751
GSM549103patient 117, normal, homogenized [OPG study]5.1962443
GSM549117patient 073, normal, homogenized [OPG study]5.0372742
GSM549138patient 041, cancer, homogenized [OPG study]5.4426249
GSM549141patient 045, cancer, homogenized [OPG study]5.5519151
GSM549130patient 028, cancer, homogenized [OPG study]5.5012350
GSM549101patient 111, normal, homogenized [OPG study]4.9271138
GSM549105patient 128, normal, homogenized [OPG study]5.2760445
GSM549106patient 134, normal, homogenized [OPG study]4.7424736
GSM549112patient 048, normal, homogenized [OPG study]5.2467245
GSM549125patient 011, cancer, homogenized [OPG study]5.668653
GSM549127patient 024, cancer, homogenized [OPG study]5.7433954
GSM549135patient 035, cancer, homogenized [OPG study]5.4900950